Biologics & Smell in CRSwNP: Dupilumab, Tezepelumab, Beyond

.ical

09-11, 16:30–17:30 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Johaim Mullol

<p></p>

Richard Harvey

<p></p>

This speaker also appears in:

• Rethinking Empty Nose Syndrome: identifying risk, respond to patient concers and continue effective surgery
• From Burden to Relief: Frontal Sinus Surgery
• Type 2 CRSwNP in 2026: Global variations and decision-making process in the era of biologics

Zara Patel

<p></p>

This speaker also appears in:

• Restoring Smell: Proven and Emerging Therapies
• Recalcitant Chronic Sinuistis: Diagnostic and Therapeutic Challenges in the Post-Surgical Patient
• Platelet-Rich Plasma Injections into the Olfactory Clefts of Patients with Olfactory Dysfunction: An Updated Clinical Practice
• Women in ORL